|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 47/12 | (2006.01) | ||
| C07K 16/22 | (2006.01) |
| (11) | Number of the document | 3195880 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17158990.6 |
| Date of filing the European patent application | 2011-05-11 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation | 2020-01-10 |
| (30) | Number | Date | Country code |
| 334986 P | 2010-05-14 | US |
| (72) |
OSSLUND, Timothy, D., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Didelės koncentracijos antikūno prieš sklerostiną kompozicijos |
| HIGH CONCENTRATION ANTI-SCLEROSTIN ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 15 | 289.00 EUR |
| 2026-05-11 |